Effects of glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, on markers of liver status in patients with short bowel syndrome: findings from a randomised phase 2 trial-Reference-Cited by-同舟云学术

Effects of glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, on markers of liver status in patients with short bowel syndrome: findings from a randomised phase 2 trial

Published:2019-08 Issue: Volume:46 Page:444-451
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Naimi Rahim Mohammad^ORCID,Hvistendahl Mark,Nerup Nikolaj,Ambrus Rikard,Achiam Michael Patrick,Svendsen Lars Bo,Grønbæk Henning,Møller Holger Jon,Vilstrup Hendrik,Steensberg Adam,Jeppesen Palle Bekker

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference34 articles.

1. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure;Cavicchi;Ann. Intern. Med.,2000

2. Intestinal failure-associated liver disease : what do we know today?;Kelly;Gastroenterology,2006

3. Glucagon-like peptide 2 improves cholestasis in parenteral nutrition-associated liver disease;Lim;JPEN J. Parenter. Enteral Nutr.,2016

4. Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease;Pereira-Fantini;J. Hepatol.,2014

5. Assessment of intestinal failure associated liver disease according to different diagnostic criteria;Sasdelli;Clin. Nutr.,2018

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapy in the Management of Intestinal Failure: An Updated Review of Current Therapies and Beyond;Current Treatment Options in Gastroenterology;2024-07-06

2. Targeting the GLP-2 receptor in the management of obesity;Peptides;2024-07

3. Efficacy and safety of glucagon-like peptide 2 in patients with short bowel syndrome: a systematic review and network meta-analysis;Journal of Gastrointestinal Surgery;2024-07

4. Noninvasive liver fibrosis markers are independently associated with carotid atherosclerosis risk in patients with nonalcoholic fatty liver disease;Scandinavian Journal of Gastroenterology;2024-06-22

5. ESPEN guideline on chronic intestinal failure in adults – Update 2023;Clinical Nutrition;2023-10